Method for detecting the presence of a gynaecological growth
AssigneeSingapore Volition Pte Limited
InventorsJacob Vincent Micallef, Mark Edward Eccleston
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for detecting the presence of a gynaecological growth, in particular for the diagnosis of endometriosis. The invention also relates to a method of identifying a biomarker for detecting the presence of a gynaecological growth and to biomarkers identified by said method.
Claims18
A method for detecting the presence of a gynaecological growth which comprises the steps of:
- (i) determining the day or phase of the menstrual cycle;
- (ii) taking body fluid samples at two or more different times during the menstrual cycle, characterised in that a first sample is taken during the menses phase of the menstrual cycle and a second sample is taken during the luteal phase of the menstrual cycle;
- (iii) measuring nucleosomes or a component part thereof in the body fluid samples;
- and
- (iv) using the levels of nucleosome or a component part thereof in, and the difference in biomarker levels between, the two samples as an indicator of the presence of a gynaecological growth.
A method for detecting the presence of a gynaecological growth which comprises the steps of:
- (i) administering to a subject an exogenous hormone, or hormone analogue, or hormone agonist, or hormone antagonist or a drug or contraceptive steroid or other substance intended to induce a gynaecological response in a stimulation or repression test;
- and
- (ii) measuring nucleosomes or a component part thereof in a body fluid;
- and
- (iii) determining whether the amount or nature of the nucleosomes or component part thereof present in the body fluid of the subject is altered by the administration of the said exogenous substance such that any cell death as detected by the release of nucleosomes or component part thereof, is associated with a gynaecological growth.
A method for identifying a nucleosome component biomarker for detecting the presence of a gynaecological growth which comprises the steps of:
- (i) determining the day or phase of the menstrual cycle;
- (ii) taking body fluid samples at two or more different times during the menstrual cycle, characterised in that a first sample is taken during the menses phase of the menstrual cycle and a second sample is taken during either the follicular or luteal phase of the menstrual cycle;
- (iii) measuring nucleosomes or a component part thereof in said first and second samples;
- and
- (iv) determining whether the amount or nature of nucleosomes or component part thereof is controlled or influenced by the menstrual cycle, such that control or influence indicates the identity of a biomarker.
Dependencies are inferred from the claim text.